MetLife Investment Management’s Crocs CROX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.88M | Sell |
23,902
-810
| -3% | -$88.5K | 0.01% | 930 |
|
|
2026
Q1 | $2.05M | Sell |
24,712
-628
| -2% | -$53.8K | 0.01% | 1045 |
|
|
2025
Q4 | $2.17M | Sell |
25,340
-2,727
| -10% | -$228K | 0.01% | 1038 |
|
|
2025
Q3 | $2.34M | Sell |
28,067
-2,099
| -7% | -$192K | 0.01% | 1012 |
|
|
2025
Q2 | $3.06M | Sell |
30,166
-1,428
| -5% | -$146K | 0.02% | 789 |
|
|
2025
Q1 | $3.36M | Sell |
31,594
-1,691
| -5% | -$175K | 0.02% | 811 |
|
|
2024
Q4 | $3.65M | Buy |
33,285
+2,104
| +7% | +$245K | 0.02% | 736 |
|
|
2024
Q3 | $4.52M | Sell |
31,181
-1,258
| -4% | -$172K | 0.03% | 587 |
|
|
2024
Q2 | $4.73M | Sell |
32,439
-3,266
| -9% | -$458K | 0.03% | 514 |
|
|
2024
Q1 | $5.13M | Sell |
35,705
-957
| -3% | -$109K | 0.03% | 473 |
|
|
2023
Q4 | $3.42M | Sell |
36,662
-1,182
| -3% | -$109K | 0.02% | 699 |
|
|
2023
Q3 | $3.34M | Sell |
37,844
-1,836
| -5% | -$189K | 0.03% | 651 |
|
|
2023
Q2 | $4.46M | Sell |
39,680
-28,789
| -42% | -$3.43M | 0.03% | 518 |
|
|
2023
Q1 | $8.66M | Sell |
68,469
-1,015
| -1% | -$123K | 0.06% | 246 |
|
|
2022
Q4 | $7.53M | Sell |
69,484
-1,145
| -2% | -$101K | 0.06% | 277 |
|
|
2022
Q3 | $4.85M | Buy |
70,629
+845
| +1% | +$58.7K | 0.04% | 423 |
|
|
2022
Q2 | $3.4M | Buy |
69,784
+1,865
| +3% | +$113K | 0.03% | 656 |
|
|
2022
Q1 | $5.19M | Buy |
67,919
+19,430
| +40% | +$1.84M | 0.03% | 504 |
|
|
2021
Q4 | $6.22M | Sell |
48,489
-2,847
| -6% | -$439K | 0.05% | 312 |
|
|
2021
Q3 | $7.37M | Sell |
51,336
-4,154
| -7% | -$570K | 0.07% | 243 |
|
|
2021
Q2 | $6.47M | Buy |
55,490
+30,448
| +122% | +$3M | 0.06% | 287 |
|
|
2021
Q1 | $2.01M | Sell |
25,042
-1,394
| -5% | -$106K | 0.02% | 865 |
|
|
2020
Q4 | $1.66M | Sell |
26,436
-1,654
| -6% | -$94.4K | 0.02% | 915 |
|
|
2020
Q3 | $1.2M | Sell |
28,090
-2,328
| -8% | -$90K | 0.01% | 944 |
|
|
2020
Q2 | $1.12M | Buy |
30,418
+1,900
| +7% | +$50.3K | 0.01% | 985 |
|
|
2020
Q1 | $485K | Hold |
28,518
| – | – | 0.01% | 1238 |
|
|
2019
Q4 | $1.19M | Hold |
28,518
| – | – | 0.01% | 1010 |
|
|
2019
Q3 | $792K | Hold |
28,518
| – | – | 0.01% | 1177 |
|
|
2019
Q2 | $563K | Sell |
28,518
-57,036
| -67% | -$1.32M | 0.01% | 1409 |
|
|
2019
Q1 | $2.2M | Buy |
85,554
+57,036
| +200% | +$1.56M | 0.01% | 1196 |
|
|
2018
Q4 | $741K | Sell |
28,518
-3,451
| -11% | -$80.7K | 0.01% | 1146 |
|
|
2018
Q3 | $681K | Hold |
31,969
| – | – | 0.01% | 1337 |
|
|
2018
Q2 | $563K | Hold |
31,969
| – | – | 0.01% | 1338 |
|
|
2018
Q1 | $519K | Buy |
31,969
+5,056
| +19% | +$70.1K | 0.01% | 1343 |
|
|
2017
Q4 | $340K | Buy |
+26,913
| New | +$288K | ﹤0.01% | 1633 |
|
Other funds holding CROX
MetLife Investment Management's CROX Position: Q2 2026 in Review
MetLife Investment Management reduced its Crocs (CROX) stake by 3.3% in Q2 2026, selling an estimated $88.5K and leaving 23,902 shares worth $2.88M. The position accounts for 0.01% of the portfolio, ranked #930.
MetLife Investment Management first reported a position in CROX in Q4 2017 and has held it in 35 quarters since. The position peaked at $8.66M in Q1 2023. 501 funds tracked by Wall St. Rank hold CROX as of Q2 2026.
- MetLife Investment Management held 23,902 shares of Crocs worth $2.88M as of Q2 2026.
- MetLife Investment Management sold 810 Crocs shares in Q2 2026, an estimated $88.5K.
- Crocs made up 0.01% of MetLife Investment Management's portfolio in Q2 2026, its #930 holding.
- MetLife Investment Management first reported a position in Crocs in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Crocs position peaked at $8.66M in Q1 2023.
- 501 funds tracked by Wall St. Rank held Crocs as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.